ACH

$0.28+7.32%visit website

ACCENDRA HEALTH INC/VA/

Market Cap

$22M

Live price × SEC shares (Jun 30, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

1.56

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

0.0

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

6.1

TTM to Jun 2026 · EV incl. net debt

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	697,264	708,967	627,780	613,234	2,647,245
Cost of revenue	375,067	385,709	349,752	349,827	1,460,355
Selling, general & administrative	265,838	271,499	255,226	243,560	1,036,123
Operating income	26,470	20,909	17,125	(35,150)	29,354
Interest expense	29,029	27,931	32,348	34,539	123,847
Pretax income	(3,635)	(7,971)	(16,246)	(87,628)	(115,480)
Income tax	1,972	1,472	(9,778)	1,442	(4,892)
Net income	(150,276)	(56,326)	(6,468)	(89,070)	(302,140)
EPS (basic) ($)	(1.94)		(0.08)	(1.16)	(3.96)
EPS (diluted) ($)	(1.94)		(0.08)	(1.16)	(3.96)
Weighted avg. shares (basic)	77,288		76,432	76,695
Weighted avg. shares (diluted)	77,288		76,432	76,695

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 10, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 65 more quarters, back to Jun 2009, with Tormere Pro.

Corporate Events (8-K)

22 filings in 12 months · 2 with priority itemsFull history →

Filed	Items	Filing
Nov 3, 2026 accepted 4:41 PM ET	5.02Officer / director change	Document SEC ↗
Nov 2, 2026 accepted 6:50 AM ET	1.01Material agreement7.01Reg FD disclosure	Document SEC ↗
Oct 30, 2026 accepted 4:50 PM ET	3.01Delisting notice7.01Reg FD disclosure	Document SEC ↗
Oct 9, 2026 accepted 4:10 PM ET	3.01Delisting notice7.01Reg FD disclosure	Document SEC ↗
Sep 28, 2026 accepted 5:06 PM ET	8-K/A 5.02Officer / director change	Document SEC ↗
Sep 17, 2026 accepted 6:35 AM ET	5.02Officer / director change7.01Reg FD disclosure8.01Other events	Document SEC ↗
Aug 17, 2026 accepted 6:42 AM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 10, 2026 accepted 4:15 PM ET	1.01Material agreement3.03Holder rights modified5.03Bylaws / fiscal year7.01Reg FD disclosure	Document SEC ↗
Aug 10, 2026 accepted 6:50 AM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Aug 10, 2026 accepted 6:36 AM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

59%

W/W -15.7pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

No Form 4 transactions on record.

Recent News

Accendra Health, Inc. (ACH) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2026-11-03

Accendra Health(ACH) Stock Options Chain | Quotes & News

Moomoo · 2026-11-02

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga · 2026-11-02

Accendra Health (ACH) Extends Receivables Sale Program, Shares S

GuruFocus · 2026-11-02

Accendra Health, Inc. (ACH) stock price, news, quote and history

Yahoo Finance UK · 2026-11-02

Accendra Health Announces Extension of $150 Million Receivables Sale Program To 2029

Yahoo · 2026-11-02

Accendra Health Extends $150M Receivables Purchase Agreement To October 2029 With Its Size Unchanged

Benzinga · 2026-11-02

Accendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders’ Equity; Intends to Submit Business Plan and Return to Compliance with NYSE Listing Standard

Yahoo · 2026-10-30

Accendra Health Consensus Price Target Decreased by 16.53% to $1.29

Fintel · 2026-10-23

Accendra Health Announces Third Quarter 2026 Earnings Release Date and Conference Call

Yahoo · 2026-10-22

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga · 2026-10-21

Postmarket Movers for Oct. 16, 2026: BitFuFu, Zone Frontier Among Gainers; ATA Creativity, Zhibao Among Losers

ChartMill · 2026-10-16

12 Health Care Stocks Moving In Wednesday's After-Market Session

Benzinga · 2026-10-14

Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard

Yahoo · 2026-10-09

New Strong Sell Stocks for October 9th

Yahoo · 2026-10-09

Informational purposes only, not investment advice.

Corporate Events (8-K)

22 filings in 12 months · 2 with priority itemsFull history →

Filed	Items	Filing
Nov 3, 2026 accepted 4:41 PM ET	5.02Officer / director change	Document SEC ↗
Nov 2, 2026 accepted 6:50 AM ET	1.01Material agreement7.01Reg FD disclosure	Document SEC ↗
Oct 30, 2026 accepted 4:50 PM ET	3.01Delisting notice7.01Reg FD disclosure	Document SEC ↗
Oct 9, 2026 accepted 4:10 PM ET	3.01Delisting notice7.01Reg FD disclosure	Document SEC ↗
Sep 28, 2026 accepted 5:06 PM ET	8-K/A 5.02Officer / director change	Document SEC ↗
Sep 17, 2026 accepted 6:35 AM ET	5.02Officer / director change7.01Reg FD disclosure8.01Other events	Document SEC ↗
Aug 17, 2026 accepted 6:42 AM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 10, 2026 accepted 4:15 PM ET	1.01Material agreement3.03Holder rights modified5.03Bylaws / fiscal year7.01Reg FD disclosure	Document SEC ↗
Aug 10, 2026 accepted 6:50 AM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Aug 10, 2026 accepted 6:36 AM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗

ACH

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

ACCENDRA HEALTH INC/VA/ (ACH)

Factor Profile

Corporate Events (8-K)